BackTriSalus Life Sciences Overview

TriSalus Life Sciences Receivables

Latest receivables for TLSI: $5.2M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$5.21M
↓ 4.36% YoYΔ $-238000.00 vs prior year quarter

Peer average

Loading

TriSalus Life Sciences Receivables History

Loading

TriSalus Life Sciences vs. peers: Receivables Comparison

Loading

TriSalus Life Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TriSalus Life Sciences (TLSI) FAQ

TriSalus Life Sciences (TLSI) currently reports a receivables of $5.2M as of March 2026. That compares with $5.5M in the prior-year period — down 4.4% year over year. Use the charts on this page to explore TriSalus Life Sciences's receivables history and peer comparisons.

TriSalus Life Sciences's receivables decreased from $5.5M to $5.2M — a 4.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TriSalus Life Sciences reported $5.2M in receivables as of March 2026. That compares with $5.5M in the prior-year period — down 4.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $5.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TriSalus Life Sciences, and consider following TLSI for alerts when major investors trade the stock.